Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virological response after switching to Atripla on an empty stomach in treatment-experienced HIV-1 patients
2007-005769-36Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tenofovir disoproxil fumarate in Human immunodeficiency virus infection type 1, sponsored by Gilead Sciences. Primary endpoint: Pure virologic response through Week 48. Started Mar 2008; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2007-005769-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005769-36.